Prion diseases are rare, deadly neurodegenerative brain diseases that result from misfolding protein. Recent study encourages the development of antibodies to PrPC to prevent its conversion to PrPSc. If successful, their unique approach illuminates treatment for prion and other like diseases
Subscribe to:
Post Comments (Atom)
< + > The Payment Integrity Reckoning
The following is a guest article by Mark Noel , SVP and GM of ClaimInsight at AMPS Why transparency and defensibility have become non-negot...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Solution Erases Long Phone Holds for Patients, Supports Overwhelmed Medical Front Desk Workers, and Improves Patient Access to Physicians A...
-
Announcement written by Zack Kanter, Founder and CEO at Stedi In February of last year, I gathered our engineering team in a war room. Chan...
No comments:
Post a Comment